Jose Roberto Soares da Silva
Corporate Officer/Principal presso BIOLAB SANUS Farmacêutica Ltda.
Profilo
Jose Roberto Soares da Silva is currently the Head-Business Development & Innovation Director at BIOLAB SANUS Farmacêutica Ltda.
Posizioni attive di Jose Roberto Soares da Silva
Società | Posizione | Inizio |
---|---|---|
BIOLAB SANUS Farmacêutica Ltda.
BIOLAB SANUS Farmacêutica Ltda. Pharmaceuticals: MajorHealth Technology BIOLAB is a Brazilian pharmaceutical corporation which develops, manufactures and commercializes medicines. BIOLAB is proud to be a benchmark in health products innovation. BIOLAB's core business is to produce prescription medicines in cardiology, rheumatology, orthopedics, general practice, pediatrics, endocrinology, geriatrics and dermatology. Following a global trend, they are massively investing in dermocosmetics, developing products to meet the requirements of the country's different weather characteristics, the different types of skin, and the use of natural resources from its biodiversity. BIOLAB is a leader in cardiovascular product prescriptions and ranks 8th in prescription drug sales. BIOLAB carries in its DNA the vocation for research, as a fundamental way for the development of new products and technologies. Since the company was founded, investment in research has allowed the launch of four exclusive products. | Corporate Officer/Principal | 01/05/2003 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
BIOLAB SANUS Farmacêutica Ltda.
BIOLAB SANUS Farmacêutica Ltda. Pharmaceuticals: MajorHealth Technology BIOLAB is a Brazilian pharmaceutical corporation which develops, manufactures and commercializes medicines. BIOLAB is proud to be a benchmark in health products innovation. BIOLAB's core business is to produce prescription medicines in cardiology, rheumatology, orthopedics, general practice, pediatrics, endocrinology, geriatrics and dermatology. Following a global trend, they are massively investing in dermocosmetics, developing products to meet the requirements of the country's different weather characteristics, the different types of skin, and the use of natural resources from its biodiversity. BIOLAB is a leader in cardiovascular product prescriptions and ranks 8th in prescription drug sales. BIOLAB carries in its DNA the vocation for research, as a fundamental way for the development of new products and technologies. Since the company was founded, investment in research has allowed the launch of four exclusive products. | Health Technology |
- Borsa valori
- Insiders
- Jose Roberto Soares da Silva